We are live on ! Find out more
PLSE icon

Pulse Biosciences
PLSE

31 hedge funds and large institutions have $5.28M invested in Pulse Biosciences in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $4.38M → $5.28M (+$892K)

1.68% less ownership

Funds ownership: 8.26% → 6.58% (-1.7%)

30% less funds holding

Funds holding: 44 → 31 (-13)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

Holders
31
Holders Change
-13
Holders Change %
-29.55%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
12
Closed
15
Calls
$1.29M
Puts
–
Net Calls
+$1.29M
Net Calls Change
+$1.16M

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$35.7K
2
GAM
Griffin Asset Management
New York
+$28.2K
3
Citigroup
Citigroup
New York
+$7.11K
4
Group One Trading
Group One Trading
Illinois
+$4.45K
5
Northern Trust
Northern Trust
Illinois
+$3.44K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$457K
2
Citadel Advisors
Citadel Advisors
Florida
-$103K
3
Millennium Management
Millennium Management
New York
-$100K
4
JMPWA
JP Morgan Private Wealth Advisors
California
-$73K
5
WIM
Westside Investment Management
California
-$54.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
WIM
26
Westside Investment Management
California
$332 -$54.4K -33,472 -19%
Citadel Advisors
27
Citadel Advisors
Florida
– -$103K -63,401 Closed
OQS
28
Occudo Quantitative Strategies
Florida
– -$54K -58,383 Closed
JMPWA
29
JP Morgan Private Wealth Advisors
California
– -$73K -48,000 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
– -$49K -31,827 Closed
SSA
31
Schonfeld Strategic Advisors
New York
– -$40K -26,300 Closed
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
– -$27K -17,600 Closed
Deutsche Bank
33
Deutsche Bank
Germany
– -$23K -14,919 Closed
Goldman Sachs
34
Goldman Sachs
New York
– -$19K -12,173 Closed
CAPTRUST Financial Advisors
35
CAPTRUST Financial Advisors
North Carolina
– -$13K -8,311 Closed
TRCT
36
Tower Research Capital (TRC)
New York
– -$6K -4,131 Closed
Simplex Trading
37
Simplex Trading
Illinois
– -$2.39K -1,474 Closed
Fifth Third Bancorp
38
Fifth Third Bancorp
Ohio
– -$2K -1,146 Closed
UBS Group
39
UBS Group
Switzerland
– -$1.14K -703 -88%
Barclays
40
Barclays
United Kingdom
– -$383 -236 -52%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– +$3 +2 +2%
1
2

PLSE Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2022, worth a combined $5.28M — up 20% from $4.38M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PLSE and 3 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 6 added.

The largest buyer was Osaic Holdings, adding an estimated $35.7K. The largest seller was Morgan Stanley, cutting an estimated $457K.

  • 31 institutional investors held Pulse Biosciences (PLSE) as of Q3 2022, down from 44 in Q2 2022.
  • Funds reported $5.28M of Pulse Biosciences stock for Q3 2022, up 20% quarter-over-quarter.
  • 3 funds opened new Pulse Biosciences positions in Q3 2022 and 15 closed out, a net change of -12 holders.
  • The largest Pulse Biosciences buyer in Q3 2022 was Osaic Holdings, an estimated $35.7K added.
  • The largest Pulse Biosciences seller in Q3 2022 was Morgan Stanley, an estimated $457K sold.

Based on aggregated 13F filings for Q3 2022.